Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?

CONCLUSION: For cN2 TN or HER2+ breast cancer patients who achieve breast pCR following NAT, consideration could be given to downstaging and performing an axillary SLNB or TAD.PMID:38277714 | PMC:PMC10832498 | DOI:10.1016/j.breast.2024.103671

Source: Breast - January 26, 2024 Category: Cancer & Oncology Authors: Xuhui Guo Jiao Zhang Xilong Gong Jia Wang Hao Dai Dechuang Jiao Rui Ling Yi Zhao Hongjian Yang Yunjiang Liu Ke Liu Jianguo Zhang Dahua Mao Jianjun He Zhigang Yu Yinhua Liu Peifen Fu Jiandong Wang Hongchuan Jiang Zuowei Zhao Xingsong Tian Zhongwei Cao Keji Source Type: research